Postmenopausal Women: Clinical Trials

3 trials for Postmenopausal Women, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 withdrawn. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 22Active not recruiting 1, Withdrawn 1

Follow Postmenopausal Women: new trials by email Literature Review of Postmenopausal Women trials Research Report on Postmenopausal Women

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Single Dose of BL0175 in Postmenopausal Women
BL0175, Fulvestrant - Postmenopausal Women
Phase 1Not yet recruitingShanghai Best-Link Bioscience, LLC272026-01-262026-01-26
Tocotrienols for Skeletal Muscle Health
placebo softgel, DeltaGoldĀ® Tocotrienol 70% - Dynapenia, Postmenopausal Women
Phase 1 / Phase 2WithdrawnTexas Tech University Health Sciences Center2019-04-152022-02-18
Tocotrienols for Obesity of Postmenopausal Women
placebo softgel, DeltaGoldĀ® Tocotrienol 70% - Obesity, Postmenopausal Women
Phase 1 / Phase 2Active not recruitingTexas Tech University Health Sciences Center602019-03-152026-10-02

Narrower conditions

Obesity (1)

Broader conditions

Body Weight (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Olive Oil (2)  ·  Tocotrienols (2)  ·  Fulvestrant (1)

Sponsors

Texas Tech University Health Sciences Center (2)  ·  Shanghai Best-Link Bioscience, LLC (1)

Countries

United States (2)

Top investigators

Chwan-Li Shen, PhD (2)

Results publications

PMID 32152169